Exchange: NASDAQ·Updated 07:55 AM EDT
QNRX logo

QNRX Quoin Pharmaceuticals Ltd - ADR

$6.80
$0.00
(0.00%)
Pre-Market
Prev Close $6.80
Mkt Cap$13.66M
Vol672.00

About QNRX

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.
42

Bearish Sentiment

How do you feel about QNRX?

Advertisement|Remove ads.